Drug-drug Interactions With Anti-tuberculous Drugs

ConditionDrug-drug Interaction

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorCairo University

About this trial

This study aims to assess the prevalence and the outcome of prescribing drugs known to have major drug-drug interactions with anti-tuberculous drugs among Kasr Alainy tuberculous patients.

Eligibility criteria

Qualifiers

All patients diagnosed with tuberculosis and referred to Tuberculosis outpatient clinic, Kasr Alainy Faculty of Medicine, Cairo University, starting after the obtaining of the Scientific/Ethical approval of the study protocol.

Disqualifiers

Refusal by the patient/patient's guardian to participate in this study

Trial design

Treatments tested in this trial

Anti Tuberculosis Drug

Treatment groups

400 Participants

are divided into 1 treatment group

Sponsors and collaborators

Cairo University

Lead sponsor

Source ClinicalTrials.gov